The Journal of invasive cardiology

publication venue for

TAVR in a 65-Year-Old Man With a Bicuspid Aortic Valve With Extremely Large Annulus and Severe Left Ventricular Dysfunction. 2020
Transcatheter Tricuspid Valve-in-Valve Replacement Via Right Internal Jugular Vein Access in a 39-Year-Old Woman. 2019
Treatment of Diffuse Right Coronary Aneurysmal Disease With Standard Drug-Eluting Stent Scaffolding of Polytetrafluoroethylene-Covered Stents. 2018
Very Late Migration of Balloon-Expandable Transcatheter Aortic Valve. 2018
Atrial Septal Defect Closure for Right-to-Left Shunting Following a MitraClip Repair. 2016
Novel use of an apical-femoral wire rail to assist with transfemoral transcatheter aortic valve replacement. 2014
Pheochromocytoma found in Takotsubo cardiomyopathy patients. 2014
Left main coronary thrombotic occlusion due to secondary polycythemia in a normal sinus of valsalva. 2013
Chemotherapy-induced takotsubo cardiomyopathy. 2008
Novel intracoronary steerable support catheter for complex coronary intervention. 2006
The bent stent. 2002
Immediate post-operative balloon dilatation of neonatal long segment stenosis of the descending thoracic aorta. 2001
Use of the Ostial Flash balloon in aorto-ostial chronic total occlusion percutaneous coronary intervention. 2025
Heartbeats and bank statements: a survey of the financial pulse of cardiologists. 2024
Ranolazine in chronic total occlusion percutaneous coronary intervention.. 36. 2024
Artificial intelligence for predicting primary antegrade wiring success of chronic total occlusion crossing. 2024
Geographic diversity in chronic total occlusion percutaneous coronary intervention: insights from the PROGRESS-CTO registry.. 36. 2024
Comparing upfront catheter-based thrombectomy with alternative treatment strategies for clot-in-transit. 2024
Peripheral artery disease in chronic total occlusion percutaneous coronary intervention. 2024
Redo transcatheter aortic valve replacement in a young patient with congenital aortic valve disease. 2024
Evaluating the hemodynamic impact of saddle versus non-saddle pulmonary embolism: insights from a thrombectomy cohort. 2024
Predictors of successful primary antegrade wiring in chronic total occlusion percutaneous coronary intervention.. 36. 2024
Outcomes with treatment interventions for clot-in-transit in patients with pulmonary embolism: a meta-analysis. 2024
Validation of the J-Channel Score for retrograde channel crossing in the PROGRESS-CTO registry.. 36. 2024
Equipment entrapment/loss during chronic total occlusion percutaneous coronary intervention.. 36. 2024
Use of plaque modification microcatheters during percutaneous coronary interventions for chronic total occlusion: insights from the PROGRESS-CTO Registry. 2024
Racial disparities in chronic total occlusion percutaneous coronary interventions: insights from the PROGRESS-CTO registry.. 36. 2024
Lesion complexity and procedural outcomes associated with ostial chronic total occlusions: Insights from the PROGRESS-CTO Registry.. 35. 2023
Impact of target vessel on the procedural techniques and outcomes of chronic total occlusion percutaneous coronary intervention.. 35. 2023
Atrial fibrillation and chronic total occlusion percutaneous coronary intervention outcomes: insights from the Progress-CTO registry.. 35. 2023
Diagnosis related group and outcomes following transcatheter aortic valve implantation.. 35. 2023
Frequency and outcomes of ad hoc chronic total occlusion percutaneous coronary intervention: insights from the progress-cto registry.. 35. 2023
Use of Bivalirudin for Chronic Total Occlusion Percutaneous Intervention: Insights From the PROGRESS-CTO Registry.. 35. 2023
Equipment Utilization in Chronic Total Occlusion Percutaneous Coronary Interventions: Update From the PROGRESS-CTO Registry.. 35. 2023
Body Mass Index and Chronic Total Occlusion Percutaneous Coronary Intervention Outcomes: Is Overweight the New Normal?. 35. 2023
Outcomes of Patients With Acute Coronary Syndromes Undergoing Chronic Total Occlusion Percutaneous Coronary Intervention.. 35. 2022
Saphenous Vein Graft Occlusion Following Native Vessel Chronic Total Occlusion Percutaneous Coronary Intervention.. 34. 2022
Primary vs Secondary Retrograde Approach in Chronic Total Occlusion Percutaneous Coronary Interventions.. 34. 2022
Association of Annual Operator Volume With the Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention.. 34. 2022
Endovascular eSheath Predilation to Facilitate Transfemoral Transcatheter Aortic Valve Delivery.. 34. 2022
Adverse Events With Intravascular Lithotripsy After Peripheral and Off-Label Coronary Use: A Report From the FDA MAUDE Database.. 33. 2021
Characteristics and Outcomes of Patients With Acute Coronary Syndrome Who Received Percutaneous Coronary Intervention During Snowy Days.. 33. 2021
Procedural and In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Interventions in Patients With Acute Myocardial Infarction: Insights From a Prospective Multicenter International Registry.. 33. 2021
Distal Radial Access in Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the PROGRESS-CTO Registry.. 33. 2021
Balloon Aortic Valvuloplasty With Same-Setting Complex Percutaneous Coronary Intervention in the TAVR Era: A Case Series.. 33. 2021
Intravascular Ultrasound Insights Into Perforation After Coronary Atherectomy.. 33. 2021
Impact of Intravascular Ultrasound Utilization for Stent Optimization on 1-Year Outcomes After Chronic Total Occlusion Percutaneous Coronary Intervention.. 32. 2020
Urologic Complications in Patients Receiving Indwelling Urinary Catheters During Transcatheter Aortic Valve Replacement.. 32. 2020
Impact of Successful Chronic Total Occlusion Percutaneous Coronary Interventions on Subsequent Clinical Outcomes.. 32. 2020
Follow-up Outcomes After Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With and Without Prior Coronary Artery Bypass Graft Surgery: Insights From the PROGRESS-CTO Registry.. 32. 2020
Use of Polymer-Jacketed, Tapered-Tip, Low-Force Guidewires With Composite-Core, Dual-Coil Design as Part of the Antegrade Approach to Coronary Chronic Total Occlusions.. 32. 2020
Temporal Trends in Chronic Total Occlusion Percutaneous Coronary Interventions: Insights From the PROGRESS-CTO Registry.. 32. 2020
Impact of Severity of Chronic Kidney Disease on Management and Outcomes Following Transcatheter Aortic Valve Replacement With Newer-Generation Transcatheter Valves.. 32. 2019
Left Main Chronic Total Occlusion Percutaneous Coronary Intervention: A Case Series.. 31. 2019
Intact and Isolated Human Cadaveric Coronary Artery Perfusion Models to Facilitate Research and Education Regarding Coronary Anatomy and Pathology.. 31. 2019
Frequency and Outcomes of Ad Hoc Versus Planned Chronic Total Occlusion Percutaneous Coronary Intervention: Multicenter Experience.. 31. 2019
Comparison Between Traditional and Guide-Catheter Extension Reverse Controlled Antegrade Dissection and Retrograde Tracking: Insights From the PROGRESS-CTO Registry.. 31. 2018
Mechanical Circulatory Support in Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Multicenter U.S. Registry.. 30. 2018
Retrograde CTO-PCI of Native Coronary Arteries Via Left Internal Mammary Artery Grafts: Insights From a Multicenter U.S. Registry.. 30. 2017
Early Transcatheter Aortic Valve Function With and Without Therapeutic Anticoagulation.. 29. 2017
Outcomes After Successful Percutaneous Coronary Intervention of Calcified Lesions Using Rotational Atherectomy, Cutting-Balloon Angioplasty, or Balloon-Only Angioplasty Before Drug-Eluting Stent Implantation.. 29. 2017
The Impact of Proximal Vessel Tortuosity on the Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Contemporary Multicenter Registry.. 29. 2017
Impact of Chronic Total Occlusions on Revascularization Scores and Outcome Prediction.. 29. 2017
The Impact of Age and Sex on In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention.. 29. 2017
The SYNTAX Score Does Not Predict Risk of Adverse Events in Patients With Non-ST Elevation Acute Coronary Syndrome Who Undergo Coronary Artery Bypass Graft Surgery.. 29. 2016
Impact of Proximal Cap Ambiguity on Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Multicenter US Registry.. 28. 2016
Contrast Utilization During Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Contemporary Multicenter Registry.. 28. 2016
Right Atrial Vacuum-Assisted Thrombectomy: Single-Center Experience.. 28. 2016
Impact of Chronic Statin Therapy on Postprocedural Contrast-Induced Nephropathy in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention.. 27. 2015
A prospective, randomized, pivotal trial of a novel extravascular collagen-based closure device compared to manual compression in diagnostic and interventional patients.. 27. 2015
Comparison of provisional 1-stent and 2-stent strategies in diabetic patients with true bifurcation lesions: the EES bifurcation study.. 26. 2014
Inappropriate use of the appropriate use criteria (AUC) as a guide for reimbursement.. 26. 2014
Atherectomy for calcified femoropopliteal disease: are we making progress?. 26. 2014
Impact of peripheral vascular disease on short- and long-term outcomes in patients undergoing non-emergent percutaneous coronary intervention in the drug-eluting stent era.. 25. 2013
Use of low-dose heparin with bivalirudin for ad-hoc transradial coronary interventions: experience from a single center.. 23. 2011
Transradial approach to subclavian artery stenting.. 22. 2010
Efficacy and safety of bivalirudin in patients with diabetes mellitus undergoing percutaneous coronary intervention in current clinical practice.. 22. 2010
ST-elevation myocardial infarction mortality in a major academic center "on-" versus "off-" hours.. 21. 2009
Frequency and outcomes of provisional glycoprotein IIb/IIIa blockade in patients receiving bivalirudin during percutaneous coronary intervention.. 21. 2009
Initial clinical experience using an ostial stent positioning system (Ostial Pro) for the accurate placement of stents in the treatment of coronary aorto-ostial lesions.. 21. 2009
The role of out-of-hospital cardiac arrest in predicting hospital mortality for percutaneous coronary interventions in the Clinical Outcomes Assessment Program.. 21. 2009
Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding.. 18. 2006
A new percutaneous porcine coronary model of chronic total occlusion.. 17. 2005
Effects of focused force angioplasty: pre-clinical experience and clinical confirmation.. 17. 2005
The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results.. 15. 2003
Durable clinical benefit following Sr90 Beta irradiation therapy for in-stent restenosis in high-volume community practice.. 15 Suppl A. 2003
Low-molecular-weight heparins.. 13 Suppl A. 2001
Enoxaparin and abciximab adjunctive pharmacotherapy during percutaneous coronary intervention.. 13. 2001
Putting heparin into perspective: its history and the evolution of its use during percutaneous coronary interventions.. 12 Suppl F. 2000
Initial and Long-Term Results of Treatment of Brachiocephalic Arterial Stenoses and Occlusions with Balloon Angioplasty, Thrombolysis, Stents.. 9. 1997
Active Guidewire Technique: Using Guidewire Bias to Assist in Rotational Atherectomy.. 9. 1997
Angiographic Results and Late Clinical Outcomes Utilizing a Stent Synergy (Pre-Stent Atheroablation) Approach in Complex Lesion Subsets.. 8. 1996
Clinical Benefit within Patient Subgroups Receiving c7E3 Fab (Abciximab) During Percutaneous Coronary Revascularization: Subgroup Analysis from the EPIC Trial.. 8 Suppl B. 1996
"Rescue" platelet GP IIb/IIIa inhibitor therapy in percutaneous coronary intervention: bailing out of a sunken ship. 2000
A Need For Long-Term Results of LMCA-CTO-PCI. 2019
Transpedal Access for the Management of Complex Peripheral Artery Disease. 2017
Update on chronic total occlusion percutaneous coronary intervention. 2024
Update on Chronic Total Occlusion Percutaneous Coronary Intervention. 2023
A Systematic Review and Meta-Analysis of Clinical Outcomes of Patients Undergoing Chronic Total Occlusion Percutaneous Coronary Intervention. 2022
Sex-Related Differences in Early- and Long-Term Mortality After Transcatheter and Surgical Aortic Valve Replacement: A Systematic Review and Meta-Analysis. 2020
Myocardial revascularization in patients with left main coronary disease. 2013
Vascular changes and black hole phenomenon after coronary brachytherapy: a pathologically distinct entity. 2008
Alcohol septal ablation for failed surgical myectomy. 2005
Mechanical thrombectomy in deep venous thrombosis. 2004
Vascular brachytherapy and the strontium90 vascular brachytherapy system. 2003
Bivalirudin, thrombin and platelets: clinical implications and future directions. 2003
Arrhythmogenic right ventricular dysplasia and the implantable cardioverter-defibrillator: a case report and review of the literature. 2000
Palmaz-Schatz stent implantation in the treatment of saphenous vein graft lesions. 1995

VIVO Weill Cornell Medical College

The Journal of invasive cardiology Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)